LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

The new Osia® System with Osia OSI300 Implant enables patients to undergo MRI at 3.0 Tesla (T) without the need for surgery This has been made possible by the OSI300's unique Piezo Power™ technology ...

Australian and European Patent Offices Grant the Company Four Patents Relating to Key Innovations in Implantable System ...

BOAO, China, June 20, 2025 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa™ System - the world's first and only smart cochlear ...

In a major regulatory win, Cochlear ($COH)--the world's largest maker of cochlear implants--scored FDA approval for its next-generation device to treat sensorineural ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

WHITE BEAR LAKE, MN - Envoy Medical (TASE:PMCN)®, Inc. (NASDAQ: COCH), a small-cap medical device company with a market capitalization of $29.4 million specializing in hearing loss solutions, has ...

Cochlear Limited, the global leader in implantable hearing solutions, has announced the launch in New Zealand of its most advanced hearing solution – Cochlear™ Nucleus® 6. This next generation sound ...

Upgradeable Firmware: The Cochlear™ Nucleus ® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates.

Xinyu Li, General Manager, Greater China, Cochlear, explains the next generation technology has completely reimagined the internal components of the hearing device: "There are more than 10 years of ...